Preparation and biological activity of amino acid and peptide conjugates of antitumor hydroxymethylacylfulvene

Journal of Medicinal Chemistry

Volumn 43, Issue 19, 2000, Pages 3577-3580

  McMorris, T C ^a   Yu, J ^a   Ngo, H T ^a   Wang, H ^a   Kelner, M J ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UCSD MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6 HYDROXYMETHYLACYLFULVENE; ACETYLCYSTEINE; AMINO ACID DERIVATIVE; ANTINEOPLASTIC AGENT; CAPTOPRIL; CYCLOPROPANE; CYSTEINE; GLUTATHIONE; GLYCINE; HOMOCYSTEINE; ILLUDIN S; LEUCINE; PEPTIDE DERIVATIVE; PHENYLALANINE; SULFURIC ACID; THIOL DERIVATIVE; TRIPEPTIDE;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG CONJUGATION; DRUG CYTOTOXICITY; HYDROPHILICITY; LUNG CARCINOMA; NONHUMAN; PEPTIDE SYNTHESIS; PH; ULTRAVIOLET SPECTROSCOPY;

AMINO ACIDS; ANIMALS; ANTINEOPLASTIC AGENTS; DRUG SCREENING ASSAYS, ANTITUMOR; INHIBITORY CONCENTRATION 50; PEPTIDES; RATS; SESQUITERPENES; TUMOR CELLS, CULTURED;

EID: 0034699437     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm0000315     Document Type: Article

References (14)

1. (Hydroxymethyl)acylfulvene: An illudin derivative with superior antitumor properties
2. The structures of the basidiomycete metabolites illudin S and illudin M
3. Preclinical evaluation of illudins as anticancer agents
4. Preclinical antitumor activity of 6-Hydroxymethylacylfulvene, a semisynthetic derivative of the mushroom toxin illudin S
5. Clinical trials of MGI-114
6. On the mechanism of toxicity of illudins: The role of glutathione
7. Metabolism of illudin S, a toxic substance of Lampteromyces japonicus: Urinary excretion of mercapturic acids in rat
8. Acylfulvenes, a new class of potent antitumor agents
9. Metabolism of antitumor acylfulvene by rat liver cytosol
10. Efficacy of acylfulvene illudin analogues against a metastatic lung carcinoma MV 522 xenograft nonresponsive to traditional anticancer agents: Retention of activity against various mdr phenotypes and unusual cytotoxicity against ERCC2 and ERCC3 DNA Helicase-deficient cells
11. Reaction of antitumor hydroxymethylacylfulvene (HMAF) with thiols
12. Inappropriate renin secretion unmasked by captopril (SQ14225) in hypertension of chronic renal failure
13. Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model